| 000 | 01678 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518005822.0 | ||
| 264 | 0 | _c20200309 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1130-0108 | ||
| 024 | 7 |
_a10.17235/reed.2018.5667/2018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGutiérrez García, María Luisa | |
| 245 | 0 | 0 |
_aHepatitis B virus in patients with chronic hepatitis C treated with direct antiviral agents. _h[electronic resource] |
| 260 |
_bRevista espanola de enfermedades digestivas _cFeb 2019 |
||
| 300 |
_a129-133 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCoinfection _xvirology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xanalysis |
| 650 | 0 | 4 |
_aHepatitis B virus _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 | _aVirus Activation |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aManzano Alonso, María Luisa | |
| 700 | 1 | _aFerrer Rosique, Juan Ángel | |
| 700 | 1 | _aMuñoz Gómez, Raquel | |
| 700 | 1 | _aAlonso López, Sonia | |
| 700 | 1 | _aFernández Álvarez, Inmaculada | |
| 700 | 1 | _aFernández Rodríguez, Conrado M | |
| 773 | 0 |
_tRevista espanola de enfermedades digestivas _gvol. 111 _gno. 2 _gp. 129-133 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.17235/reed.2018.5667/2018 _zAvailable from publisher's website |
| 999 |
_c29037575 _d29037575 |
||